Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Duffy

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
British Journal of Cancer|June 1, 1980
Plasma concentrations of the platelet-specific beta-thromboglobulin in malignant diseaseR J Farrell, M J Duffy, M J Moriarty, et al.
Irish Journal of Medical Science|October 1, 1985
Ca-19-9, a new marker for gastrointestinal malignancyM J Duffy, F O'Sullivan, D O'Donoghue, et al.
Breast Cancer Research : BCR|March 16, 2001
Metalloproteinases: role in breast carcinogenesis, invasion and metastasisM J Duffy, T M Maguire, A Hill, et al.
Irish Journal of Medical Science|January 1, 1989
CA 125 as a tumour marker in epithelial ovarian cancerJ D Sheehan, M J Duffy, M A Allen, et al.
Journal of the National Cancer Institute|September 1, 1986
Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptorsM J Duffy, P O'Grady, J Simon, et al.
Lancet (London, England)|January 13, 1990
Urokinase plasminogen activator and prognosis in breast cancerM J Duffy, D Reilly, C O'Sullivan, et al.
Irish Medical Journal|September 15, 1978
Biochemical markers in breast carcinomaM J Duffy, N Hynes, Y Groarke, et al.
International Journal of Cancer|February 13, 1999
High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancerK McCarthy, T Maguire, G McGreal, et al.
British Journal of Cancer|April 1, 1980
Serum sialic acid and CEA concentrations in human breast cancerA Hogan-Ryan, J J Fennelly, M Jones, et al.
Clinical Endocrinology|July 1, 1990
The overnight dexamethasone test is a worthwhile screening procedureC Cronin, D Igoe, M J Duffy, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
British Journal of Cancer|June 1, 1980
Plasma concentrations of the platelet-specific beta-thromboglobulin in malignant diseaseR J Farrell, M J Duffy, M J Moriarty, et al.
Irish Journal of Medical Science|October 1, 1985
Ca-19-9, a new marker for gastrointestinal malignancyM J Duffy, F O'Sullivan, D O'Donoghue, et al.
Breast Cancer Research : BCR|March 16, 2001
Metalloproteinases: role in breast carcinogenesis, invasion and metastasisM J Duffy, T M Maguire, A Hill, et al.
Irish Journal of Medical Science|January 1, 1989
CA 125 as a tumour marker in epithelial ovarian cancerJ D Sheehan, M J Duffy, M A Allen, et al.
Journal of the National Cancer Institute|September 1, 1986
Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptorsM J Duffy, P O'Grady, J Simon, et al.
Lancet (London, England)|January 13, 1990
Urokinase plasminogen activator and prognosis in breast cancerM J Duffy, D Reilly, C O'Sullivan, et al.
Irish Medical Journal|September 15, 1978
Biochemical markers in breast carcinomaM J Duffy, N Hynes, Y Groarke, et al.
International Journal of Cancer|February 13, 1999
High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancerK McCarthy, T Maguire, G McGreal, et al.
British Journal of Cancer|April 1, 1980
Serum sialic acid and CEA concentrations in human breast cancerA Hogan-Ryan, J J Fennelly, M Jones, et al.
Clinical Endocrinology|July 1, 1990
The overnight dexamethasone test is a worthwhile screening procedureC Cronin, D Igoe, M J Duffy, et al.
Pageof 17